Veterinary Diagnostics

To place an order, please choose your country

Subscribe newsletter

SARS-CoV-2 / Covid-19

ID Screen® SARS-CoV-2-N IgG Indirect ELISA

ELISA

A highly reliable serology test to detect IgG antibodies against SARS-CoV-2

Indirect semi-quantitative ELISA for the specific detection of IgG antibodies against the nucleocapsid of SARS-CoV-2 in human serum and plasma.

For research use only.

RUO logo

Advantages

Specifications

Format

Reliable:

  • Approved by French authorities further to its evaluation by the French National Reference Centre
  • High sensitivity and specificity (99.9%) ensures accurate results, with clear discrimination of positive and negative samples
  • Excellent specificity and high positive predictive value, even in low prevalence areas, means a positive result reliably indicates if a person has been exposed to the virus and if the patient has developed antibodies

Rapid and easy-to-use:

  • Use manually or with any open automated immunoassay platform
  • Ready-to-use reagents
  • Results in 95 minutes
  • Possibility to operate on inactivated serum/plasma samples to guarantee operator’s safety

Method :

Semi-quantitative indirect ELISA

Species :

Humans

Specimens :

Serum or plasma

Coated antigen :

Purified recombinant antigen

Conjugate :

Protein G-HRP conjugate (concentrated 10X)

Marking :

CE-IVD

Product reference

Kit format

Reactions

Plate format

SARSCOV2S-4P 4 plates 384 12 x 8-well strips
SARSCOV2S-8P 8 plates 768 12 x 8-well strips